Evidence map›Paper›PMID 33669635›Full record

ArticlePathogens (Basel, Switzerland)2021

Hypothiocyanite and Hypothiocyanite/Lactoferrin Mixture Exhibit Virucidal Activity In Vitro against SARS-CoV-2.

Luca Cegolon, Mattia Mirandola, Claudio Salaris, Maria Vittoria Salvati, Giuseppe Mastrangelo, Cristiano Salata

Open access · goldAbstract read
In one paragraph

Article in Pathogens (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
4.7field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 31 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Milk Antiviral Proteins and Derived Peptides against Zoonoses.International journal of molecular sciences · 2024
    Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. Review
  17. Review
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Luca CegolonPublic Health Department, Local Health Unit N.2 "Marca Trevigiana", 31100 Treviso, Italy.ORCID 0000-0002-6285-7355
Mattia MirandolaDepartment of Molecular Medicine, University of Padova, 35121 Padova, Italy.ORCID 0000-0001-7145-3443
Claudio SalarisDepartment of Molecular Medicine, University of Padova, 35121 Padova, Italy.ORCID 0000-0002-6998-8550
Maria Vittoria SalvatiDepartment of Molecular Medicine, University of Padova, 35121 Padova, Italy.
Giuseppe MastrangeloDepartment of Cardiac, Thoracic, Vascular Sciences & Public Health, University of Padova, 35121 Padova, Italy.
Cristiano SalataDepartment of Molecular Medicine, University of Padova, 35121 Padova, Italy.ORCID 0000-0002-5136-7406
University of Padua · ITAULSS 2 Marca Trevigiana · IT

Funding

Università degli Studi di Padova DOR-2019 and DOR-2020
6 · The paper itself

Abstract

SARS-CoV-2 replicates efficiently in the upper airways during the prodromal stage, resulting in environmental viral shedding from patients with active COVID-19 as well as from asymptomatic individuals. There is a need to find pharmacological interventions to mitigate the spread of COVID-19. Hypothiocyanite and lactoferrin are molecules of the innate immune system with a large spectrum cidal activity. The Food and Drug Administration and the European Medicines Agency designated the hypothiocyanite and lactoferrin combination as an orphan drug. We report an in vitro study showing that micromolar concentrations of hypothiocyanite exhibit dose- and time-dependent virucidal activity against SARS-CoV-2 and that the latter is slightly enhanced by the simultaneous presence of lactoferrin.

Indexed as

ALX-009COVID-19hypothiocyanitelactoferrinlactoperoxidase systemSARS-CoV-2

Identifiers

PMID33669635
PMCPMC7922920
OpenAlexW3130703392

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.